Boxer Capital

Boxer Capital as of Dec. 31, 2018

Portfolio Holdings for Boxer Capital

Boxer Capital holds 24 positions in its portfolio as reported in the December 2018 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Beigene (BGNE) 15.6 $126M 900k 140.26
Solid Biosciences 11.6 $94M 3.5M 26.80
Ptc Therapeutics I (PTCT) 9.1 $74M 2.2M 34.32
Wave Life Sciences (WVE) 8.6 $69M 1.7M 42.04
Mirati Therapeutics 8.2 $66M 1.6M 42.42
Intercept Pharmaceuticals In 7.5 $61M 600k 100.79
Esperion Therapeutics (ESPR) 6.8 $55M 1.2M 46.00
Odonate Therapeutics Ord 5.2 $42M 3.0M 14.08
Uniqure Nv (QURE) 4.3 $35M 1.2M 28.82
Rocket Pharmaceuticals (RCKT) 3.6 $29M 2.0M 14.82
Dbv Technologies S A (DBVT) 3.6 $29M 4.5M 6.42
Global Blood Therapeutics In 3.5 $29M 700k 41.05
Amarin Corporation (AMRN) 2.5 $20M 1.5M 13.61
Cymabay Therapeutics 2.0 $17M 2.1M 7.87
Immunomedics 2.0 $16M 1.2M 14.27
Kura Oncology (KURA) 1.5 $12M 845k 14.04
Kiniksa Pharmaceuticals (KNSA) 1.0 $8.2M 291k 28.09
Mei Pharma 0.9 $7.7M 2.9M 2.64
Esperion Therapeutics Inc Ne 0.6 $4.6M 100k 46.00
Medicines Company 0.6 $4.4M 232k 19.14
Kalvista Pharmaceuticals (KALV) 0.5 $4.0M 200k 19.75
Matinas Biopharma Holdings, In (MTNB) 0.4 $3.4M 5.6M 0.60
Reata Pharmaceuticals Inc Cl A 0.3 $2.8M 50k 56.10
Novus Therapeutics 0.1 $519k 324k 1.60